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had an equivalent negative impact. 
Indeed, participants in a 2007 workshop 
sponsored by the National Academy 
of Sciences, entitled ‘Genetically 
Engineered Organisms, Wildlife, and 
Habitat’, agreed on the importance of 
proper comparisons. Referring to the 
findings of meeting participant LaReesa 
Wolfenbarger from University of 
Nebraska, a summary of the workshop 
said, “The conclusion Wolfenbarger 
drew from these studies was that GE 
crops do affect wildlife food, but that 
variations in agricultural practices, 
including cultivation itself, and the use 
of insecticides, can have larger effects.”
The other significant concern among 
environmentalists and scientists alike 
is the potential for gene flow between 
GM crops and wild flora to erode 
biodiversity. The worry is that if GM 
crops are grown in close proximity to 
wild species that are closely related, 
hybridization between the two could 
lead to genetic contamination. This is 
especially likely if the gene introduced 
into the wild population confers a 
fitness advantage, allowing it to spread 
via natural selection. The issue has 
been of particular concern in places 
like Mexico where numerous landraces 
of maize and its wild progenitors are 
grown next to each other. In fact, the 
Mexican government has banned 
the planting of GM maize since 1998. 
Despite the ban, several recent studies 
have found evidence of GM genetic 
material in cultivated maize grown in 
Mexico, though it’s unclear from where 
this material originated. 
At this stage, there are many 
unknowns when it comes to the 
potential impact on biodiversity. In 
those cases where the potential for 
hybridization is low, such as maize 
grown in the US, the risk is likely 
minimal. But what about crops like 
sunflowers, pecans, blueberries, and 
some squashes, which are native 
to the US? Should GM versions of 
these crops emerge, is there cause 
for concern? As advocated in the 
2007 workshop, when the potential 
for hybridization does exist, it will be 
necessary to both quantify the extent 
of gene flow between populations 
and, importantly, assess the potential 
fitness advantages conferred by the 
genes in question. However, as in the 
question of food safety, it’s not clear 
that the environmental issues raised by 
GM crops should be any different from 
traditionally created varieties. Both have 
the potential to affect wild gene pools.
Weighing the risks
As with any technology, at some point 
there has to be a cost/benefit analysis 
done. While all of the food safety scares 
surrounding GM food continue to be 
debunked as fast as they materialize, 
there are no doubt potential risks that 
are not yet fully understood, as can 
be seen in the ecology aspect of the 
debate. And there is nothing to say 
that new varieties of GM food could, 
in principle, potentially be harmful. On 
the other side of the ledger, however, we 
have the enormous challenge of feeding 
the world’s population, which is rapidly 
growing on a planet with finite resources. 
Of course, malnourishment has many 
causes, including local politics and war, 
but agricultural technology will certainly 
factor importantly. And GM food has 
lived up to its promise of providing 
increased yields with less pesticide use 
and at a lower cost to the consumer. 
Not only this, but genetic engineering 
has the potential to provide much 
needed micronutrients (i.e., vitamins) 
to the malnourished of the world. A 
case in point is the recent development 
of an engineered form of rice that 
produces a precursor of vitamin A, 
dubbed ‘golden rice’. This remarkable 
and easily implementable technology 
has the potential to mitigate hundreds 
of thousands of cases of blindness in 
the developing world, and yet it remains 
shelved due to unsubstantiated health 
concerns. 
Many western consumers can 
afford to stock their refrigerators with 
organic produce, but can the rest of 
the world? Do the potential risks really 
trump malnourishment and starvation? 
While the interested parties continue 
to debate, science marches on. On the 
horizon are GM crops that can grow in 
inhospitable corners of the earth, such 
as the dry and salty environs. And we 
are now seeing the application of GM 
technology to animals, such as salmon 
engineered to reach market weight 
more quickly through the expression 
of genes encoding growth hormones. 
Whether these technologies are taken 
up or left to gather dust on the shelf 
will likely depend on the ability of 
scientists and the government to make 
a convincing case to the public. If they 
fail, we potentially handcuff ourselves 
and will be forced to rely on 20th century 
technology to solve 21st century 
problems. 
Cyrus Martin is Senior Scientific Editor at 
Current Biology.Does the gut 
microbiome hold 
clues to obesity and 
diabetes? 
As high-throughput genome 
sequencing technology now enables 
researchers to study the microbiota in 
our digestive system both in breadth 
and in detail, the hope is that mysteries 
of common problems, including 
obesity and diabetes, will finally be 
solved. Michael Gross reports. 
In antiquity, soothsayers used to inspect 
the entrails of animals, specifically 
the liver and intestines, to derive 
information about people’s fates. One 
famous example of the practice resulted 
in the warning to Julius Caesar to 
“beware the Ides of March”. 
Modern times have been quick to 
dismiss this procedure, known as 
extispicy, which was widespread from 
the Hittites through to the Etruscans 
and Romans, as pure superstition. 
Now that we have learned to decipher 
DNA sequences, the fate of each living 
thing and each person (apart from 
unpredictable external influences) is 
surely to be read from their genomes. 
Accordingly, researchers have studied 
genomes in great detail and learned a 
lot about evolution, development, and 
biological function, but they still haven’t 
discovered the ultimate causes for 
common problems like obesity, heart 
disease, diabetes, and autism. 
Maybe the clues to a person’s fate 
are in the intestines after all? Since 
the publication of the first catalogue 
of microbial genes from human guts, 
the ‘gut microbiome’ (i.e. the collective 
genome of the resident species) 
in 2010, genomic analysis of our 
commensal bacteria has become a 
widely used approach that could even 
be called fashionable. But first signs 
are indicating that some of the long-lost 
answers to important medical questions 
may actually show up in the intestines. 
Life inside us
In March 2010, researchers from the 
BGI in Shenzhen, China, and the 
international MetaHIT (Metagenomics of 
the Human Intestinal Tract) consortium 
reported a catalogue of 3.3 million 
different gene sequences from human 
intestines, representing around  
150 times as many genes as are found 
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Gutsy guests: Bacterial cells in our bowels outnumber our own body cells ten to one, and they 
carry more than 100 times more different genes than our own genome. Recent research sug-
gests that the composition of the gut microbiota can have dramatic effects on human health. 
(Image: Courtesy of Mattias Bergentall and Fredrik Bäckhed, University of Gothenburg.)in the human genome (Nature (2010) 
464, 59–65). The study led by Jun Wang 
and Dusko Ehrlich created more than 
500 gigabases worth of sequence 
length using faecal samples from 124 
people. 
The researchers concluded that each 
individual typically harbours at least 
160 different bacterial species and 
that the number of species covered 
by the sequences obtained is just over 
1,000. They described a minimal gene 
complement for human gut bacteria 
as well as a minimal gut metagenome, 
defined as the set of genes represented 
in all individuals studied. 
Since then, further studies have 
added to our understanding of the 
diversity of life within our bowels. 
Recently, the groups of Peer Bork at 
the EMBL in Heidelberg, Germany 
and George Weinstock at Washington 
University, St. Louis, USA, expanded 
the range of analysis by combining 
MetaHIT’s gut metagenomes from 207 
European individuals with the results 
of the US Human Microbiome Project based on 51 individuals (Nature (2013) 
493, 45–50). 
With these data, the researchers 
carried out a detailed analysis of the 
variability of the gut metagenome. They 
identified more than 10 million single 
nucleotide polymorphisms (SNPs), 
along with more than 100,000 insertions/
deletions. In their detailed analysis of 
the SNPs, the researchers found that the 
rate of synonymous to non-synonymous 
variations is constant across individuals. 
From this, they concluded that the 
parameters specific to each human 
host are relatively unimportant for 
the evolution of the bowel bacteria 
compared to the constraints that are 
common to all humans. 
Comparing different samples 
taken from the same individual at 
time points up to one year apart, the 
researchers also found that the specific 
metagenome variation profile of each 
host individual remains constant over 
that time. However, as this part of the 
study was limited to 43 individuals and 
one year, the authors acknowledge that a longer and wider analysis is 
required to confirm that conclusion. 
Larger datasets will also be needed 
to establish which role geographical 
and ethnic divisions between human 
populations are reflected in the diversity 
of their gut microbiomes. 
Can bacteria make us fat?
Scientists are now scrutinising our 
‘second genome’ — much larger than 
the one in our cells — for clues to 
common diseases, an area where the 
search for SNPs in the human genome 
has been largely disappointing. One 
key area where the intestinal microbes 
may very well decide our fates is that of 
obesity and related diseases, such as 
diabetes and heart disease. 
Several researchers have found 
connections between the gut 
microbiota and body weight. In an early 
contribution published in 2004, Jeffrey 
Gordon’s group at the Washington 
University School of Medicine in St. 
Louis used germ-free mice to show 
that gut microbiota could make mice 
accumulate more fat by regulating 
some key genes in lipid metabolism. 
(Proc. Natl. Acad. Sci. USA (2004) 101, 
15718–15723).  
Inspired by Gordon’s findings, 
Liping Zhao, who had put on an 
unhealthy amount of weight during a 
postdoctoral stay in the US, monitored 
his gut microbial communities when 
he returned to his native China and 
embarked on a slimming programme. 
Losing 20 kg in two years with the help 
of prebiotics and traditional Chinese 
medicinal food, he also drastically 
changed the composition of his 
commensal microbiota. For instance, 
the bacterium Faecalibacterium 
prausnitzii, which is thought to have 
a beneficial, anti-inflammatory effect 
in the intestines, rose from being 
undetectable to making up 15% of his 
intestinal flora. 
Following this successful self-
medication, Zhao embarked on 
several studies into the connections 
between gut microbiomes and body 
weight, including both animal models 
and clinical trials. Most recently, he 
studied the changes of the gut flora of 
a morbidly obese volunteer who lost 
more than 50 kg starting from a peak of 
175 kg. 
Zhao and his colleague Na Fei, 
both now at the Shanghai Jiao Tong 
University in Shanghai, China, observed 
that an endotoxin-producing species of 
Enterobacter was the most drastically 
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Holding up: Although there is no shortage of reminders that obesity leads to a whole host of 
health problems, the richer countries are in the grip of an obesity epidemic that resists all edu-
cational approaches. Gut microflora is likely to be part of the problem and may also help to find 
new solutions. (Image: iStockphoto.)reduced microbial species during 
that transition. The species had made 
up 35% of the microbiota before 
the slimming course, and became 
undetectable after 23 weeks. After 
transplanting an isolated strain of this 
bacterium into the guts of germfree 
mice, which are normally resistant to 
gaining weight from a high-fat diet, 
they found that all mice fed a high-fat 
diet became obese (except one which 
died from an infection in the first week). 
The researchers concluded that this 
Enterobacter species is likely to be 
causally linked to obesity in humans 
(ISME J. (2013) 7, 880–884). 
“As we followed the essence of 
Koch’s postulates for identifying the 
pathogen for a disease, we regard this 
strain of Enterobacter as a ‘pathogen’ 
for obesity disease,” Zhao explains. 
“We expect to find more such ‘obesity 
pathogens’ following the protocol 
established in this study.”
… or thin? 
Intestinal bacteria may even be behind 
weight-loss effects hitherto considered 
as purely a question of plumbing. 
The groups of Peter Turnbaugh at 
Massachusetts General Hospital and 
Lee Kaplan at Harvard University 
showed that gastric bypass operations 
(technically referred to as Roux-en-Y 
gastric bypass or RYGB) induce shifts in 
the gut microbiota, and that a transplant 
of bacterial communities has exactly the 
same slimming effect as the operation 
(Sci. Transl. Med. (2013) 5, 178ra41). 
Thus, instead of invasive surgery, 
patients with dangerous obesity might 
in the future be treated with faecal 
transplants from slimmer people. 
At the moment, the ‘yuck factor’ 
and the poorly defined nature of 
the cure, which might also contain 
pathogens, means that only a few 
doctors are transplanting faeces, 
and only in situations where no other 
treatment exists, such as severe 
Clostridium difficile infections. This 
opportunistic bacterium can invade 
the guts when the native bacterial 
community is decimated by broad-
spectrum antibiotics, and is therefore 
very difficult to treat with antibiotics. 
In the last chapter of her new book, 
Gulp: Adventures on the Alimentary 
Canal, famously fearless science writer 
Mary Roach investigates the current use 
of faecal transplants. She reports that 
Alexander Khoruts from the University 
of Minnesota has so far carried out 
more than 40 such transplants to treat C. difficile problems, with a 
success rate of over 90%. She traces 
the practice back to the 1950s, when 
doctors tried out bacterial transfers as 
a way to combat severe diarrhoea after 
early antibiotics treatments. 
The group of Max Nieuwdorp at the 
Academic Medical Centre in Amsterdam, 
Netherlands, carried out a clinical trial to 
assess the effects of faecal transplants 
on patients with metabolic syndrome, 
a type of obesity linked to insulin 
resistance and identified as a risk factor 
for diabetes. The placebo-controlled trial 
found that the insulin response nearly 
doubled in morbidly obese patients six 
weeks after infusion with gut microbiota 
from lean donors (Gastroenterology 
(2012) 143, 913–916). 
In a follow-up study, researchers 
from the same institution are now 
investigating whether multiple transfers 
have a stronger long-term beneficial 
effect than a single transfer (trial 
registration number: NTR 2705). 
Hormones have their say
Just how the gut microbiota interact 
with their hosts and can make them 
thin or obese remains to be fully 
understood. One additional complexity 
comes from the involvement of 
hormones, which may also explain 
gender bias in certain disorders related 
to metabolism. 
The group of Jayne Danska at the 
Hospital for Sick Children in Toronto, 
Canada, studied the three-way interactions between microbiota, 
hormones, and host metabolism in a 
mouse model of type 1 diabetes known 
as non-obese diabetic (NOD) mice. 
The research found that commensal 
microbes can elevate testosterone 
levels of the host, which in turn protects 
the host from type 1 diabetes. This 
protection depends on the function of 
androgen receptors (Science (2013) 339, 
1084–1088). 
In the mouse model — unlike in the 
human population, where the disease 
onset is typically before puberty — 
females are more at risk of type 1 
diabetes. However, transplanting gut 
microbiota from adult male mice to 
immature females, the researchers 
were able to reduce the females’ risk to 
a level comparable to that of the males. 
By contrast, NOD mice lacking a bowel 
flora (germ-free conditions) had a very 
similar diabetes risk for both sexes. 
Screening for metabolites, the 
researchers identified a group of 
glycerophospholipid and sphingolipid 
metabolites that are markedly different 
in mice harbouring the typically male or 
typically female microbiota. Like other 
sex differences, these microbiome 
differences appear to emerge with 
sexual maturation. 
Another recent study has found 
similar sex differences between fatty 
acids in humans (PLoS Genet. (2011) 
7, e1002215). From this, Danska 
and colleagues conclude that the 
underlying principles are conserved 
Current Biology Vol 23 No 9
R362
Frugal fishing at 
hand
The European Union is on the cusp of 
major reforms to its fishing industry. 
First up on the agenda is a ban on 
fish discarding that is expected to 
be approved in June. But as Cyrus 
Martin reports, the solutions are 
complex, involving a combination 
of improved technology, better 
enforcement, and creative thinking.
In late February, the European 
Council of Ministers emerged from an 
overnight session with the news that 
they had finally reached an agreement 
on legislation to ban fish discards, 
the wasteful practice of throwing 
perfectly edible fish overboard. In 
recent years, it is estimated that 25% 
of the fish caught in EU waters, on 
average, are discarded, though this 
figure fluctuates widely depending on 
the species and fishery in question. 
Many of the fish heaved over the side 
are already dead or dying and benefit 
no one save the seagulls circling 
overhead. While clearly a priority, the 
proposed ban on fish discards is just 
one pillar of a much broader effort 
to reform the Common Fisheries 
Policy, which outlines the rules and 
regulations governing EU fisheries. 
Highlighting the need for reform, 
a recent report from the European 
Commission suggested that perhaps 
75% of species in EU waters are 
overfished, and the Commission has 
put forward a range of proposals 
to both rescue fisheries that are in 
danger of collapse and promote 
sustainable fishing practices more 
generally.
EU policy makers have modeled 
their reforms on what are seen as 
successful management schemes 
elsewhere. The US approach in 
particular has served as a template 
with its comprehensive Magnuson-
Stevens Fishery Conservation and 
Management Act, which in 2007 
was overhauled in response to 
data suggesting overfishing in US 
waters. Part of the problem in the US 
was older, ineffective management 
schemes, such as approaches that 
dealt with the problem of overfishing 
by limiting the length of the fishing 
season, a window that could be 
adjusted based on the perceived 
health of fish stocks. This created 
a competitive situation among 
fishermen that led to greater fishing 
effort in the form of bigger boats and 
more sophisticated technology, a 
battle played out in popular television 
shows such as The Deadliest Catch. 
The end result of this marine arms 
race was and is overfishing, which 
in turn leads to even shorter fishing 
seasons, starting the cycle anew. 
Not only does fishing become 
unsustainable under this scheme but 
the consumer suffers as well, as the 
short but intense fishing season leads 
to unpredictable gluts of product on 
the market and unstable prices. 
To address the issue of overfishing, 
one of the key provisions of the 
updated Magnuson-Stevens Act 
is to set fishing quotas on each 
species and mandate that such 
quotas are set with the goal of 
achieving the maximum sustainable 
yield from the fishery. In the past, 
the total allowable catch in the US 
was influenced heavily by interested 
parties, such as the fishermen and 
processors, leading to inflated quotas 
and overfishing. Critically, the total 
allowable catch under the current 
US system is determined based on 
scientific advice, a practice European 
reformers hope to reinforce with 
the new reforms. And to specifically 
address the issue of competition 
between fishermen, the Magnuson-
Stevens Act encourages the use of 
catch-share systems, in which each 
fisherman is allotted an individual 
quota, allowing him/her to fish at 
their leisure.
Though quotas are seen as the way 
forward, when combined with other 
factors they ironically can lead to 
increased fish discarding. At the heart 
of the problem is the crude nature of 
industrial fishing itself, in which huge 
trawling nets are dragged across 
the ocean bottom, collecting both 
target and non-target species alike. 
Under traditional quota systems, a 
boat might only be able to legally 
land certain species of fish and, 
though economically valuable, other 
species would have to be thrown 
overboard. In the past, vessels would 
illegally bring these fish to the black 
market by conspiring with producers 
on shore. This problem recently 
plagued the Scottish mackerel fishery, 
and the fishery is rather unique in 
Europe in having been answerable 
to the law. As fisheries scientist 
Paul Fernandes explains, “This was 
probably commonplace up until between mice and human and 
that a similar triangular regulation 
network between gut microbiota, sex 
hormones, and lipid metabolism also 
exists in humans and may hold clues 
to understanding and treating type 
1 diabetes and other autoimmune 
diseases such as rheumatoid arthritis 
and multiple sclerosis (which both 
have a strong female-to-male bias in 
middle age). 
Outlook
Following the first gene catalogue for 
the human gut microbiome, a rapidly 
growing volume of research has 
suggested that bowel flora could be 
very helpful in curing diseases that still 
pose challenges. Beyond the obvious 
metabolism-linked diseases like 
diabetes, some researchers have also 
suspected the bowel to be involved in 
neurological conditions such as autism. 
It is perhaps an unhelpful side 
effect of the modern knowledge about 
bacterial pathogens and hygiene 
that there are still large psychological 
barriers to be overcome. Systemic 
problems also reside in the ill-defined 
nature of microbiota transfusions and 
the lack of a route to commercialisation. 
The pharmaceutical industry will 
naturally only develop an interest 
in such faecal matters if there is 
reasonable hope of developing a 
preparation that can be patented, 
packaged, and sold at a profit. 
Researchers generally don’t have 
much patience for the yogurt industry’s 
claims of providing ‘friendly bacteria’ 
for our bowels, as many crucial species 
are anaerobic and wouldn’t survive 
administration via yogurt. Still, it does 
not appear completely impossible that 
a generic package with helpful bacteria 
for our bowels can be developed. 
Still, the ancient cultures weren’t 
entirely wrong about consulting 
intestines to find out about people’s 
fate. It has been argued that prehistoric 
herders may in fact have come up with 
the practice in an attempt to find out 
about health problems in their herds by 
autopsy. 
In any case, it now seems plausible 
that people’s chances for a long and 
healthy life depend not only on their 
genes and general good luck, but also 
on the specific composition of the 
microbial communities in their guts. 
Michael Gross is a science writer based at 
Oxford. He can be contacted via his web page 
at www.michaelgross.co.uk
